Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan. | Int J Clin Oncol | 2021 | 33385275 | PubTator, text mining | PubMed |
| Novel PI3K/Akt/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy. | Int J Oncol | 2021 | 33367926 | PubTator, text mining | PubMed |
| The ubiquitin ligase RFWD3 is required for translesion DNA synthesis. | Mol Cell | 2021 | 33321094 | PubTator, text mining | PubMed |
| Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19. | J Infect | 2021 | 33259846 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma-backbone or add-on in immune-oncology? | Cancer Metastasis Rev | 2021 | 33161487 | PubTator, text mining | PubMed |
| Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | Mol Cancer Res | 2021 | 33154093 | PubTator, text mining | PubMed |
| Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis. | Eur J Med Chem | 2021 | 33139113 | PubTator, text mining | PubMed |
| iCSDB: an integrated database of CRISPR screens. | Nucleic Acids Res | 2021 | 33137185 | PubTator, text mining | PubMed |
| Exploiting Replication Stress as a Novel Therapeutic Intervention. | Mol Cancer Res | 2021 | 33020173 | PubTator, text mining | PubMed |
| Genetic analysis of primary open-angle glaucoma-related risk alleles in a Korean population: the GLAU-GENDISK study. | Br J Ophthalmol | 2021 | 32933932 | PubTator, text mining | PubMed |
| Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). | J Neurochem | 2021 | 32628315 | PubTator, text mining | PubMed |
| Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions. | Cancer Drug Resist | 2020 | 35582046 | PubTator, text mining | PubMed |
| First-generation species-selective chemical probes for fluorescence imaging of human senescence-associated β-galactosidase. | Chem Sci | 2020 | 34123013 | PubTator, text mining | PubMed |
| Genomic Landscape of HCC. | Curr Hepatol Rep | 2020 | 33816052 | PubTator, text mining | PubMed |
| Dynamic Expression of m6A Regulators During Multiple Human Tissue Development and Cancers. | Front Cell Dev Biol | 2020 | 33575259 | PubTator, text mining | PubMed |
| Integrative Proteomic and Phosphoproteomic Analyses of Granulosa Cells During Follicular Atresia in Porcine. | Front Cell Dev Biol | 2020 | 33520998 | PubTator, text mining | PubMed |
| An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers. | Front Genet | 2020 | 33424936 | PubTator, text mining | PubMed |
| Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer. | Biomed Res Int | 2020 | 33381564 | PubTator, text mining | PubMed |
| Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data. | PeerJ | 2020 | 33344075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=27